Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease

The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloid, contributes to cognitive decline and dementia in Parkinson's disease (PD) is unresolved. Here, we used Florbetaben PET imaging to test for any association between cerebral amyloid deposition a...

Descripción completa

Detalles Bibliográficos
Autores principales: Melzer, Tracy R., Stark, Megan R., Keenan, Ross J., Myall, Daniel J., MacAskill, Michael R., Pitcher, Toni L., Livingston, Leslie, Grenfell, Sophie, Horne, Kyla-Louise, Young, Bob N., Pascoe, Maddie J., Almuqbel, Mustafa M., Wang, Jian, Marsh, Steven H., Miller, David H., Dalrymple-Alford, John C., Anderson, Tim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492461/
https://www.ncbi.nlm.nih.gov/pubmed/31105633
http://dx.doi.org/10.3389/fneur.2019.00391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492461/
https://www.ncbi.nlm.nih.gov/pubmed/31105633
http://dx.doi.org/10.3389/fneur.2019.00391

Ejemplares similares